Andere Sprachen Dechra Pharmaceuticals

Aktien

578968

GB0009633180

DPH

Markt geschlossen - London S.E. Andere Börsenplätze 08:30:00 16.01.2024			% 5 Tage	% 1. Jan.
3.866 ^GBX	-.--%		-.--%	+0,21 %

09.04.	Dechra Group Holdings Limited ernennt Paul Nicholas Sandland zum Direktor	CI
09.04.	Dechra Group Holdings Limited ernennt Ian David Page zum Direktor	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Dechra Pharmaceuticals Limited reached agreement in principle to acquire 33.34% stake in STEM Animal Health Inc. for $4.7 million.	11.04.
Dechra Group Holdings Limited Appoints Paul Nicholas Sandland as Director	09.04.
Dechra Group Holdings Limited Appoints Ian David Page as Director	09.04.
Dechra Group Holdings Limited Announces Resignation of Thomas Spicer as Director	09.04.
Dechra Group Holdings Limited Announces Resignation of Anthony Santospirito as Director	09.04.
Dechra Group Holdings Limited Announces Resignation of Sara Huda as Director	09.04.
Stocks slump as Fed rate cut hope dwindles	17.01.
Dechra Pharmaceuticals Delists From London Bourse Following Freya Bidco’s Takeover	17.01.
EQT's Freya Bidco Completes Dechra Pharmaceuticals Purchase	16.01.
Dechra Pharmaceuticals PLC(LSE:DPH) dropped from FTSE 100 Index	16.01.
Dechra Pharmaceuticals PLC(LSE:DPH) dropped from FTSE All-World Index	16.01.
Dechra Pharmaceuticals PLC(LSE:DPH) dropped from FTSE 350 Index	16.01.
Dechra Pharmaceuticals PLC(LSE:DPH) dropped from FTSE All-Share Index	16.01.
Dechra Pharmaceuticals PLC(LSE:DPH) dropped from FTSE 350 (Ex Investment Companies) Index	16.01.
Dechra Pharmaceuticals PLC(LSE:DPH) dropped from S&P Global BMI Index	16.01.
EQT X EUR SCSp and EQT X USD SCSp managed by Eqt Fund Management S.à R.L. and Luxinva SA (the Offerors) completed the acquisition of Dechra Pharmaceuticals PLC.	16.01.
BOLETÍN MATINAL : 12 de enero de 2024	12.01.
Persimmon to replace outbound FTSE 100 constituent Dechra	12.01.
EMEA Morning Briefing : Markets to Track Fresh Middle East Tensions	12.01.
EU clears Dechra Pharmaceuticals takeover by EQT funds	27.12.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Dechra Pharmaceuticals

Aktien

578968

GB0009633180

DPH

Andere Sprachen

Filter